Daxor announced that the United States Defense Health Agency, or DHA, has awarded the Company a $1.1M sequential Phase II Small Business Innovative Research (SBIR) contract to add the capability of electronic medical record, or EMR, integration to its small, portable, highly accurate, battery-powered blood volume analyzer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DXR:
- Daxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume Analyzer
- Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering
- Daxor announces it will exhibit BVA-100 at AAHFN
- Daxor announces the launch ezBVA Lab services
- Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference